Board of Regents, The University of Texas System patent applications published on March 21st, 2024
Summary of the patent applications from Board of Regents, The University of Texas System on March 21st, 2024
The Board of Regents, The University of Texas System, has recently filed patents for innovative technologies in various fields. These patents include a method for enhancing speech intelligibility by processing raw voice signals, a microfluidic device for high-throughput imaging, and a method for modulating the expression of the soluble isoform of the Interleukin-7 receptor using oligonucleotides.
Summary of notable applications:
- Speech processing technology for hearing aids, speech recognition software, and language learning tools.
- Microfluidic device for high-throughput imaging of biological samples, drug discovery, and cell analysis.
- Oligonucleotide method for treating autoimmune disorders and cancers by modulating the expression of the Interleukin-7 receptor.
These innovations offer benefits such as improved communication for individuals with hearing loss, enhanced imaging processes, and more targeted treatments for autoimmune disorders and cancers. The potential commercial applications include hearing aid devices, biotechnology research, and the development of novel therapeutics. Overall, these patents demonstrate the University of Texas System's commitment to advancing technology in various fields for the benefit of society.
Contents
- 1 Patent applications for Board of Regents, The University of Texas System on March 21st, 2024
- 1.1 FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION (18264125)
- 1.2 ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY (18065451)
- 1.3 APPARATUS FOR GENERATING THERAPEUTIC SHOCKWAVES AND APPLICATIONS OF SAME (18523871)
- 1.4 SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER (18487429)
- 1.5 SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER (18503125)
- 1.6 METHODS AND KITS FOR USING RECOMBINANT MICROORGANISMS AS DIRECT REAGENTS IN BIOLOGICAL APPLICATIONS (18376018)
- 1.7 HIGH-THROUGHPUT IMAGING PLATFORM (18449351)
- 1.8 Hearing Aid Device with Intonation Boosting (18466440)
Patent applications for Board of Regents, The University of Texas System on March 21st, 2024
FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION (18264125)
Main Inventor
Farshid Alambeigi
ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY (18065451)
Main Inventor
George GEORGIOU
APPARATUS FOR GENERATING THERAPEUTIC SHOCKWAVES AND APPLICATIONS OF SAME (18523871)
Main Inventor
Christopher C. CAPELLI
SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER (18487429)
Main Inventor
Mariano A. Garcia-Blanco
SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER (18503125)
Main Inventor
Mariano A. Garcia-Blanco
METHODS AND KITS FOR USING RECOMBINANT MICROORGANISMS AS DIRECT REAGENTS IN BIOLOGICAL APPLICATIONS (18376018)
Main Inventor
Andrew ELLINGTON
HIGH-THROUGHPUT IMAGING PLATFORM (18449351)
Main Inventor
Adela Ben-Yakar
Hearing Aid Device with Intonation Boosting (18466440)
Main Inventor
Eric A. Freudenthal
